Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × nelarabine × Other × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 11 Lymphoid 10 Plasma cell 1 Other 1 Myeloid 1 Dermatologic 1

Conditions

Mucositis 1 Leukemia 1

Interventions

pegaspargase 1 nelarabine 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Vitamin D 1 Vincristine 1 Therapeutics 1 Rituximab 1 Radiotherapy 1 Psychology, Positive 1 Passive Cutaneous Anaphylaxis 1 Morphine 1 Methotrexate 1 Methods 1 Methadone 1 Mercaptopurine 1 Melphalan 1 Imatinib Mesylate 1 Hydromorphone 1 High-Energy Shock Waves 1 Gelclair 1 Furosemide 1 Fibroblast Growth Factor 7 1 Etoposide 1 Drug Therapy 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Calcium Citrate 1 Calcium Carbonate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡